Market
How will Sanofi's market share in China's insulin market change by end of 2025?
2
Resolution / Starting Odds
Increase • 25%
Remain the same • 25%
Decrease • 25%
Other • 25%
Industry reports or market analysis publications
Story
Sanofi to Invest €1 Billion ($1.05 Billion) in Fourth Beijing Insulin Production Base Amid China-EU Trade Tensions
Dec 2, 2024, 09:14 PM
Sanofi, the French pharmaceutical giant, has announced plans to invest approximately 1 billion euros (around $1.05 billion) to establish a new insulin production facility in Beijing. This investment represents Sanofi's largest single investment in China to date and marks a significant move amid ongoing trade tensions between China and the European Union. The new manufacturing base will be Sanofi's fourth production and supply site in the country. The announcement was made following a memorandum of understanding signed recently, highlighting the company's commitment to expanding its operations in the region.
View original story
Similar markets
20% to 30% • 25%
More than 30% • 25%
Less than 10% • 25%
10% to 20% • 25%
Increase by over 10% • 25%
No significant change • 25%
Increase by less than 5% • 25%
Increase by 5-10% • 25%
10% to 15% increase • 25%
More than 15% increase • 25%
Less than 5% increase • 25%
5% to 10% increase • 25%
Novo Nordisk • 25%
Sanofi • 25%
Other • 25%
EMS • 25%
No • 50%
Yes • 50%
No change • 25%
Significantly increase • 25%
Decrease • 25%
Slightly increase • 25%
Construction started • 25%
None of the above • 25%
Production started • 25%
Construction completed • 25%
30% to 40% • 25%
More than 50% • 25%
40% to 50% • 25%
Less than 30% • 25%
Increase by more than 5% • 25%
Increase by 1-5% • 25%
No significant change • 25%
Decrease • 25%
Less than 10% • 25%
20% to 30% • 25%
More than 30% • 25%
10% to 20% • 25%